Monographie - Epirubicin hydrochloride

Последнее обновление :
19/11/2024

Epirubicin hydrochloride

Химическая структура

Товарное название

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Anthracine	Малайзия
Axirubicine	Германия
Bendaepi	Германия
Binarin	Мексика
Bioepycina	Польша
Crisabon	Аргентина
Cuatroepi	Аргентина
Ecclepia	Румыния
Elebicin	Мексика
Ellence	Соединённые Штаты Америки
Epi Cell	Германия
Epidoxo	Аргентина, Венесуэла, чили
Epifil	Эквадор
Epilem	Колумбия, Мексика
Epimedac	Германия
Epirubicin	Австралия, Австрия, Бельгия, Великобритания, Венгрия, Дания, Исландия, новая Зеландия, Саудовская Аравия, Турция, Швейцария, Швеция
Epirubicina	Аргентина, Испания, Колумбия, Мексика, Румыния, Эквадор
Epirubicine	Бельгия, Франция, Швейцария
Farmarubicin	Турция
Farmorubicin	Австрия, Бразилия, Греция, Дания, Норвегия, Саудовская Аравия, Финляндия, Швейцария, Швеция
Farmorubicin CSV	Южно-Африканская Республика
Farmorubicin PFS	Польша, Словения, Хорватия
Farmorubicin RD	Бразилия, Польша, Русский, Швейцария
Farmorubicin RTU	Голландия
Farmorubicina	Бразилия, Испания, Италия, Португалия
Farmorubicine	Бельгия, Франция
Pharmorubicin	Великобритания

Библиография : Epirubicin hydrochloride

	тип	публикация
148	Журнал	Dine T, Cazin JC, Gressier B, Luycks M, Brunet C, Cazin M, Goudaliez F, Mallevais ML, Toraub I. Stability and compatibility of four anthracyclines: doxorubicin, epirubicin, daunorubicin and pirarubicin with PVC infusion bags. Pharm Weekbl [Sci] 1992 ; 14: 365-369.
525	Журнал	De Vroe C, De Muynck C, Remon JP, Samsom M. A study on the stability of three antineoplastic drugs and on their sorption by IV delivery systems and end-line filters. Int J Pharm 1990 ; 65: 49-56.
683	Журнал	Walker SE, Lau DWC, DeAngelis C, Iazetta J, Coons C. Epirubicin stability in syringes and glass vials and evaluation of chemical contamination. Can J Hosp Pharm 1990 ; 43: 265-272.
686	Журнал	Wood MJ, Irwin WJ, Scott DK. Stability of doxorubicin, daunorubicin and epirubicin in plastic syringes and minibags. J Clin Pharm Ther 1990 ; 15: 279-289.
887	Журнал	Pujol M, Munoz M, Prat J, Giona V, De Bolos J. Stability study of epirubicin in NaCl 0.9% injection. Ann Pharmacotherapy 1997 ; 31: 992-995.
1237	Журнал	Keusters L, Stolk LML, Umans R, Van Asten P. Stability of solutions of doxorubicin and epirubicin in plastic minibags for intravesical use after storage at -20°C and thawing by microwave radiation. Pharm Weekbl [Sci] 1986 ; 8: 194-197.
1265	Журнал	Wood MJ, Irwin WJ, Scott DK. Photodegradation of doxorubicin, daunorubicin and epirubicin measured by high-performance liquid chromatography. J Clin Pharm Ther 1990 ; 15: 291-300.
1317	Журнал	Adams PS, Haines-Hutt RF, Bradford E, Palmer A, Rowland CG. Pharmaceutical aspects of home infusion therapy for cancer patients. Pharm J 1987 ; 238: 476-478.
1662	Журнал	Trissel LA, Saenz CA, Ingram DS, Ogundele AB. Compatibility screening of oxaliplatin during simulated Y-site administration with other drugs. J Oncol Pharm Practice 2002 ; 8: 33-37.
1823	Журнал	Sewell GJ, Rigby-Jones AE, Priston MJ. Stability of intravesical epirubicin infusion: a sequential temperature study. J Clin Pharm Ther 2003 ; 28: 349-353.
1897	Журнал	Sautou-Miranda V, Brigas F, Thibault M, Chopineau J. Compatibility of doxorubicin, daunorubicin and epirubicin with low-density polyethylene and polyvinyl chloride, and stability in various conditions of storage. EJHP 2001 ; 7, 3: 108-115.
1955	Журнал	Trissel LA, Zhang Y. Palonosetron HCl compatibility and stability with doxorubicin HCl and epirubicin HCl during simulated Y-site administration. Ann Pharmacotherapy 2005 ; 39: 280-283.
2168	Журнал	Ozdemir FA, Anilanmert B, Pekin M. Spectrophotometric investigation of the chemical compatibility of the anticancer irinotecan-HCl and epirubicin-HCl in the same infusion solution. Cancer Chemother Pharmacol 2005 ; 56, 5: 529-534.
2257	Лаборатория	Stability of epirubicin "Ebewe" infusion solutions. Ebewe Pharma 2007
3473	Журнал	Bennis Y, Savry A, Correard F, Montana M, Sauzet C, Gauthier-Villano L, Pisano P, Pourroy B. Stability of a highly concentrated solution of epirubicin for conventional transcatheter arterial chemoembolization. Int J Pharm 2015 ; 495, 2: 956-962.
3474	Лаборатория	Fluorouracil - Summary of Product Characteristics Accord Healthcare Limited 2009
3632	Лаборатория	Epirubicine (Epirubicine Hospira®) - Summary of Product Characteristics Hospira 2017
3670	Журнал	Sewell G, Massimini M. Studies on the stability and compatibility of cytotoxic drug infusion with the Tevadaptor system. EJOP 2014 ; 8, 3: 26-30.
3708	плакат	Sarakbi I, Thiesen J, Krämer I. Compatibility of epirubicin-loaded DC Beads with different contrast media. ECOP 2 Krakow 2014
3918	Журнал	Sarakbi I, Krämer I. Compatibility of epirubicin-loaded DC bead™ with different non-ionic contrast media. J Oncol Pharm Practice 2016 ; 22: 749-756.
4352	Журнал	Li J, Yao C, Xu Y, Ping P, Yin H, Sun Y. In vitro compatibility and stability of admixtures containing etoposide, epirubicin hydrochloride and vindesine sulphate in a single infusion bag. J Clin Pharm Ther 2019 ; 44: 875-882.

Mentions Légales